pneumococcal conjugate vaccine (pcv, sold as prevnar 13) (Pfizer Inc)
90
Structured Review
Pfizer Inc
pneumococcal conjugate vaccine (pcv, sold as prevnar 13)
Pneumococcal Conjugate Vaccine (Pcv, Sold As Prevnar 13), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pneumococcal+conjugate+vaccine+(pcv%2C+sold+as+prevnar+13)/prevnar+13/pm28860305-18-24-36
Average 90 stars, based on 1 article reviews
Pneumococcal Conjugate Vaccine (Pcv, Sold As Prevnar 13), supplied by Pfizer Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pneumococcal+conjugate+vaccine+(pcv%2C+sold+as+prevnar+13)/prevnar+13/pm28860305-18-24-36
Average 90 stars, based on 1 article reviews
pneumococcal conjugate vaccine (pcv, sold as prevnar 13) - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: MSF criticises India's decision to grant pneumococcal vaccine patent to Pfizer. Article Snippet: India’s decision to grant a patent on the pneumococcal conjugate vaccine (PCV, sold as Prevnar 13) to the drug company Pfizer has been criticised by the international humanitarian agency Médecins Sans Frontières (MSF).. Last month India’s patent office ruled that PCV, designed to protect against 13 strains of Streptococcus pneumoniae, met criteria for “novelty and inventiveness,” dismissing independent oppositions filed by MSF and Panacea Biotec, an Indian manufacturer.. Pfizer will now have the right to exclusively sell the vaccine in India until 2026. |